American International Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-55,832
| Closed | -$267K | – | 1805 |
|
|
2024
Q1 | $267K | Buy |
55,832
+8,492
| +18% | +$39.4K | ﹤0.01% | 1978 |
|
|
2023
Q4 | $227K | Buy |
47,340
+3,886
| +9% | +$23.8K | ﹤0.01% | 2109 |
|
|
2023
Q3 | $315K | Buy |
43,454
+1,545
| +4% | +$12.3K | ﹤0.01% | 1866 |
|
|
2023
Q2 | $311K | Buy |
41,909
+40,632
| +3,182% | +$320K | ﹤0.01% | 1933 |
|
|
2023
Q1 | $8.85K | Buy |
1,277
+82
| +7% | +$754 | ﹤0.01% | 2954 |
|
|
2022
Q4 | $12.3K | Sell |
1,195
-27
| -2% | -$476 | ﹤0.01% | 2973 |
|
|
2022
Q3 | $22K | Buy |
1,222
+4
| +0.3% | +$173 | ﹤0.01% | 2966 |
|
|
2022
Q2 | $63K | Sell |
1,218
-213
| -15% | -$11K | ﹤0.01% | 2796 |
|
|
2022
Q1 | $105K | Hold |
1,431
| – | – | ﹤0.01% | 2575 |
|
|
2021
Q4 | $205K | Sell |
1,431
-19
| -1% | -$3.27K | ﹤0.01% | 2358 |
|
|
2021
Q3 | $301K | Sell |
1,450
-111
| -7% | -$24.5K | ﹤0.01% | 2174 |
|
|
2021
Q2 | $331 | Sell |
1,561
-35,695
| -96% | -$6.54M | ﹤0.01% | 2190 |
|
|
2021
Q1 | $6.75K | Sell |
37,256
-82
| -0.2% | -$16.3K | 0.02% | 715 |
|
|
2020
Q4 | $4.16K | Buy |
37,338
+478
| +1% | +$50.8K | 0.02% | 840 |
|
|
2020
Q3 | $3.99M | Buy |
36,860
+1,215
| +3% | +$148K | 0.02% | 748 |
|
|
2020
Q2 | $2.97M | Buy |
35,645
+16,633
| +87% | +$636K | 0.01% | 832 |
|
|
2020
Q1 | $258K | Buy |
19,012
+2,374
| +14% | +$20.1K | ﹤0.01% | 1768 |
|
|
2019
Q4 | $66K | Buy |
16,638
+1,535
| +10% | +$6.66K | ﹤0.01% | 2812 |
|
|
2019
Q3 | $76K | Buy |
15,103
+182
| +1% | +$996 | ﹤0.01% | 2738 |
|
|
2019
Q2 | $87K | Buy |
14,921
+2,766
| +23% | +$21.8K | ﹤0.01% | 2754 |
|
|
2019
Q1 | $134K | Sell |
12,155
-394
| -3% | -$12.4K | ﹤0.01% | 2445 |
|
|
2018
Q4 | $462K | Sell |
12,549
-96
| -0.8% | -$3.72K | ﹤0.01% | 1717 |
|
|
2018
Q3 | $475K | Buy |
12,645
+228
| +2% | +$6.42K | ﹤0.01% | 1931 |
|
|
2018
Q2 | $333K | Buy |
12,417
+2,431
| +24% | +$82.2K | ﹤0.01% | 2078 |
|
|
2018
Q1 | $419K | Sell |
9,986
-537
| -5% | -$21.6K | ﹤0.01% | 1841 |
|
|
2017
Q4 | $261K | Buy |
10,523
+1,085
| +11% | +$26.5K | ﹤0.01% | 2162 |
|
|
2017
Q3 | $215K | Buy |
9,438
+706
| +8% | +$15.8K | ﹤0.01% | 2252 |
|
|
2017
Q2 | $201K | Buy |
8,732
+419
| +5% | +$8.22K | ﹤0.01% | 2263 |
|
|
2017
Q1 | $213K | Buy |
8,313
+549
| +7% | +$15.1K | ﹤0.01% | 2143 |
|
|
2016
Q4 | $196K | Sell |
7,764
-20
| -0.3% | -$583 | ﹤0.01% | 2186 |
|
|
2016
Q3 | $324K | Buy |
7,784
+12
| +0.2% | +$1.55K | ﹤0.01% | 1859 |
|
|
2016
Q2 | $1.13M | Sell |
7,772
-4,490
| -37% | -$515K | ﹤0.01% | 1108 |
|
|
2016
Q1 | $1.27M | Buy |
12,262
+205
| +2% | +$22K | ﹤0.01% | 1342 |
|
|
2015
Q4 | $2.02M | Buy |
12,057
+1,401
| +13% | +$216K | 0.01% | 1097 |
|
|
2015
Q3 | $1.51M | Sell |
10,656
-2,312
| -18% | -$518K | 0.01% | 1224 |
|
|
2015
Q2 | $2.89M | Buy |
12,968
+483
| +4% | +$84.9K | 0.01% | 1005 |
|
|
2015
Q1 | $2.07M | Sell |
12,485
-2,257
| -15% | -$366K | 0.01% | 1152 |
|
|
2014
Q4 | $1.75M | Buy |
14,742
+177
| +1% | +$18.5K | 0.01% | 1191 |
|
|
2014
Q3 | $1.21M | Buy |
14,565
+1,142
| +9% | +$103K | 0.01% | 1420 |
|
|
2014
Q2 | $1.24M | Buy |
13,423
+6,863
| +105% | +$603K | 0.01% | 1415 |
|
|
2014
Q1 | $594K | Sell |
6,560
-4,929
| -43% | -$551K | ﹤0.01% | 1945 |
|
|
2013
Q4 | $1.18M | Buy |
11,489
+6,914
| +151% | +$488K | 0.01% | 1366 |
|
|
2013
Q3 | $289K | Buy |
4,575
+92
| +2% | +$5.18K | ﹤0.01% | 2394 |
|
|
2013
Q2 | $184K | Buy |
+4,483
| New | +$194K | ﹤0.01% | 2652 |
|
Other funds holding NVAX
SCM
American International Group's NVAX Position: Q2 2024 in Review
American International Group sold out of Novavax (NVAX) in Q2 2024, closing a stake of 55,832 shares — an estimated $267K sold.
American International Group first reported a position in NVAX in Q2 2013 and held it in 44 quarters. The position peaked at $3.99M in Q3 2020. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.
- American International Group reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
- American International Group sold 55,832 Novavax shares in Q2 2024, an estimated $267K.
- American International Group first reported a position in Novavax in Q2 2013 and held it in 44 quarters.
- American International Group's Novavax position peaked at $3.99M in Q3 2020.
- 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.